VIVOTEK's consolidated sales revenues for October 2025 totaled USD $16.74 million, representing a 6.5 percent decrease as compared to USD $17.91 million for September 2025 and a 26.5 percent decrease as compared to USD 22.79 million for October 2024.

The Company's cumulative consolidated sales revenues from January to October in 2025 were USD $198.23 million, an 8.9 percent increase as compared to USD $182.06 million for the same period in 2024.